BUY Ajanta Pharma Limited — Ajit Mishra, Religare
byAjit Mishra, ReligareHorizon: NA (inferred 1 year)16 Nov 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·13 Nov · 3d ago
5 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·1 Nov · 2w ago
Ajanta Pharma Q2 Results: Net profit rises 49% to ₹388 crore, revenue up 33%
NewsCnbc-Tv18·30 Oct · 2w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Ajanta Pharma
- SELL — Elara Capital2 Nov 2026 · ~1 year · target ₹3,310 · Target hit
- BUY — Prabhudas Lilladher1 Nov 2026 · ~1 year · target ₹4,250 · Active
- BUY — ICICI Securities1 Nov 2026 · ~1 year · target ₹4,040 · Active
- BUY — Vinay Rajani, HDFC Securities27 Oct 2026 · ~2 weeks · target ₹3,610 · Target hit
- BUY — Sandeep Jain, Tradeswift26 Oct 2026 · ~2 weeks · target ₹3,490 · Target hit
More from Ajit Mishra, Religare
- BUY R R Kabel16 Nov 2026 · ~2 weeks · target ₹2,200 · Active
- BUY ABB India16 Nov 2026 · ~2 weeks · target ₹7,400 · Active
- BUY Bharti Hexacom16 Nov 2026 · ~2 weeks · target ₹1,860 · Active
- BUY Federal Bank12 Nov 2026 · ~2 weeks · target ₹375 · Active
- BUY Multi Commodity Exchange of India12 Nov 2026 · ~2 weeks · target ₹3,800 · Active

